2002
DOI: 10.1074/jbc.m205098200
|View full text |Cite
|
Sign up to set email alerts
|

Novel Protein Kinase C Isoforms Regulate Human Keratinocyte Differentiation by Activating a p38δ Mitogen-activated Protein Kinase Cascade That Targets CCAAT/Enhancer-binding Protein α

Abstract: The novel protein kinase C (nPKC) isoforms are important regulators of human involucrin (hINV) gene expression during keratinocyte differentiation (Efimova, T., and Eckert, R. L. (2000) J. Biol. Chem. 275, 1601-1607). Although the regulatory mechanism involves mitogenactivated protein kinase (MAPK) activation, the role of individual MAPK isoforms has not been elucidated. We therefore examined the effects of individual nPKCs on MAPK activation. We observe unique changes whereby nPKC expression simultaneously in… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

8
113
0

Year Published

2005
2005
2010
2010

Publication Types

Select...
6
2

Relationship

1
7

Authors

Journals

citations
Cited by 88 publications
(121 citation statements)
references
References 51 publications
8
113
0
Order By: Relevance
“…PKCy has been recently reported to increase the phosphorylation of p38 in various cell types (17,47). However, the role of the subcellular localization of PKCy in this effect was not reported.…”
Section: Discussionmentioning
confidence: 79%
“…PKCy has been recently reported to increase the phosphorylation of p38 in various cell types (17,47). However, the role of the subcellular localization of PKCy in this effect was not reported.…”
Section: Discussionmentioning
confidence: 79%
“…This pathway promotes expression of the differentiation markers involucrin and transglutaminase 1 (Ohba et al, 1998;Cabodi et al, 2000;Kashiwagi et al, 2000). In these cells, TPA treatment leads to p38 activation observed by 2 h. Maximum p38 activity is maintained between 6 and 24 h post-TPA (Efimova et al, 2002). E2F1 levels begin to decrease 2-4 h after TPA treatment, and reach their minimum by 10 h. Importantly, the kinetics of E2F1 loss suggest that this event occurs just downstream from or in association with p38 activation.…”
Section: Discussionmentioning
confidence: 89%
“…As noted above, involucrin expression is controlled by a novel protein kinase c (nPKC), Ras, MEKK1, MEK3 signaling cascade which ultimately acts to increase AP1 factor level and binding to the hINV promoter AP1-1 site to activate hINV gene expression (Efimova and Eckert, 2000;Efimova et al, 1998;Efimova et al, 2002;Efimova et al, 2003;Efimova et al, 2004;Eckert et al, 2004;Welter et al, 1995). Our studies indicate that EGCG activates this pathway to increase hINV gene expression, and that this response can be inhibited using BIS-IM, an agent that inhibits all PKC isoforms (Balasubramanian et al, 2002).…”
Section: Differential Regulation Of Novel Protein Kinase Cmentioning
confidence: 99%
“…Keratinocyte differentiating agents, including calcium and phorbol ester, activate involucrin gene expression Efimova et al, 2002;Efimova et al, 2003) via a signaling cascade that includes the novel PKC isoforms (nPKC), Ras, MEKK1, and MEK3 (Agarwal et al, 1999;Welter et al, 1995;Efimova and Eckert, 2000;Efimova et al, 1998). Activation of this cascade leads to an increase in p38δ and a decrease in ERK1/2 activity leading to an increase in the levels of AP1, Sp1 and CAATT enhancer binding protein (C/EBP) expression, increased binding of these factors to the hINV promoter, and increased hINV gene expression (Banks et al, 1998;Welter et al, 1995;Crish et al, 2002).…”
mentioning
confidence: 99%
See 1 more Smart Citation